Literature DB >> 25608269

Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study.

Stefano Salvatore1, Umberto Leone Roberti Maggiore, Stavros Athanasiou, Massimo Origoni, Massimo Candiani, Alberto Calligaro, Nicola Zerbinati.   

Abstract

OBJECTIVE: Microablative fractional CO2 laser has been proven to determine tissue remodeling with neoformation of collagen and elastic fibers on atrophic skin. The aim of our study is to evaluate the effects of microablative fractional CO2 laser on postmenopausal women with vulvovaginal atrophy using an ex vivo model.
METHODS: This is a prospective ex vivo cohort trial. Consecutive postmenopausal women with vulvovaginal atrophy managed with pelvic organ prolapse surgical operation were enrolled. After fascial plication, the redundant vaginal edge on one side was treated with CO2 laser (SmartXide2; DEKA Laser, Florence, Italy). Five different CO2 laser setup protocols were tested. The contralateral part of the vaginal wall was always used as control. Excessive vagina was trimmed and sent for histological evaluation to compare treated and nontreated tissues. Microscopic and ultrastructural aspects of the collagenic and elastic components of the matrix were studied, and a specific image analysis with computerized morphometry was performed. We also considered the fine cytological aspects of connective tissue proper cells, particularly fibroblasts.
RESULTS: During the study period, five women were enrolled, and 10 vaginal specimens were finally retrieved. Four different settings of CO2 laser were compared. Protocols were tested twice each to confirm histological findings. Treatment protocols were compared according to histological findings, particularly in maximal depth and connective changes achieved. All procedures were uneventful for participants.
CONCLUSIONS: This study shows that microablative fractional CO2 laser can produce a remodeling of vaginal connective tissue without causing damage to surrounding tissue.

Entities:  

Mesh:

Year:  2015        PMID: 25608269     DOI: 10.1097/GME.0000000000000401

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  33 in total

1.  Microablative fractional CO2 laser for the genitourinary syndrome of menopause: power of 30 or 40 W?

Authors:  Eleni Pitsouni; Themos Grigoriadis; Matthew Falagas; Angeliki Tsiveleka; Stefano Salvatore; Stavros Athanasiou
Journal:  Lasers Med Sci       Date:  2017-08-02       Impact factor: 3.161

2.  Computer simulations of thermal tissue remodeling during transvaginal and transurethral laser treatment of female stress urinary incontinence.

Authors:  Luke A Hardy; Chun-Hung Chang; Erinn M Myers; Michael J Kennelly; Nathaniel M Fried
Journal:  Lasers Surg Med       Date:  2016-02-22       Impact factor: 4.025

3.  Comments on Singh et al.: Laser vaginal rejuvenation: not ready for prime time.

Authors:  Umberto Leone Roberti Maggiore; Massimo Candiani; Stefano Salvatore
Journal:  Int Urogynecol J       Date:  2015-03-27       Impact factor: 2.894

4.  Laser treatment for the management of genitourinary syndrome of menopause after breast cancer. Hope or hype?

Authors:  Anastasios Tranoulis; Dimitra Georgiou; Lina Michala
Journal:  Int Urogynecol J       Date:  2019-07-18       Impact factor: 2.894

Review 5.  [Vaginal laser therapy for urinary incontinence and genitourinary syndrome of menopause : A review].

Authors:  C Ratz
Journal:  Urologe A       Date:  2019-03       Impact factor: 0.639

Review 6.  IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity.

Authors:  S Abbas Shobeiri; M H Kerkhof; Vatche A Minassian; Tony Bazi
Journal:  Int Urogynecol J       Date:  2018-12-06       Impact factor: 2.894

7.  Optical clearing of vaginal tissues, ex vivo, for minimally invasive laser treatment of female stress urinary incontinence.

Authors:  Chun-Hung Chang; Erinn M Myers; Michael J Kennelly; Nathaniel M Fried
Journal:  J Biomed Opt       Date:  2017-01-01       Impact factor: 3.170

Review 8.  Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence.

Authors:  Angamuthu Arunkalaivanan; Hervinder Kaur; Oseka Onuma
Journal:  Int Urogynecol J       Date:  2017-02-02       Impact factor: 2.894

9.  Carbon dioxide (CO2) laser ablation of symptomatic vaginal endometriosis: a pilot study.

Authors:  Laura Buggio; Ermelinda Monti; Carlo Liverani; Maria Pina Frattaruolo; Dhouha Dridi; Edgardo Somigliana
Journal:  Lasers Med Sci       Date:  2020-10-16       Impact factor: 3.161

10.  Fractional CO2 laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects.

Authors:  Angelamaria Becorpi; Giuseppina Campisciano; Nunzia Zanotta; Zelinda Tredici; Secondo Guaschino; Felice Petraglia; Annalisa Pieralli; Giovanni Sisti; Francesco De Seta; Manola Comar
Journal:  Lasers Med Sci       Date:  2018-03-01       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.